Arbor Biotechnologies
PrivateLast Round
Series C
Mar 18, 2025
Total Funding Raised
$304.5M
Company Overview
Arbor Biotechnologies is a biotechnology company that develops genomic tools leveraging AI and machine learning to enhance human health and sustainability by streamlining curative treatments for genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arbor Biotechnologies Comps
Public and private peers based on sector, stage, and business model.
Arbor Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 18, 2025 | ||||
| Series B | Nov 9, 2021 | ||||
| Series A | Aug 2, 2017 |
Key People
Founding team and executive leadership
Arbor Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series B |
| Surveyor Capital | Series C |
| S32 | Series B |
| Janus Henderson Group | Series B |
| Aberdeen Group | Series C |
| Temasek | Series C |
| TCG Crossover | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Lead program ABO-101 enters clinical trials for primary hyperoxaluria type 1.
- Oct 6, 2025
Partnered with Chiesi Group to develop gene editing programs for rare diseases.
Arbor Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arbor Biotechnologies's valuation, stock price, and market status.
